Profile
Alexandre Heraud is currently the Director at Osivax SAS since 2018.
Prior to this, he worked as an Investment Manager at Xerys Gestion SASU from 2014 to 2018.
Alexandre Heraud active positions
| Companies | Position | Start |
|---|---|---|
Osivax SAS
 Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France. | Director/Board Member | 2018-09-30 |
Former positions of Alexandre Heraud
| Companies | Position | End |
|---|---|---|
Xerys Gestion SASU
 Xerys Gestion SASU Investment ManagersFinance Xerys Gestion SASU (Xerys) is a private equity and venture capital firm headquartered in Paris, France. The firm was founded in 2000 by Jacques Simonnet. | Private Equity Investor | 2018-01-09 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Xerys Gestion SASU
Xerys Gestion SASU Investment ManagersFinance Xerys Gestion SASU (Xerys) is a private equity and venture capital firm headquartered in Paris, France. The firm was founded in 2000 by Jacques Simonnet. | Finance |
Osivax SAS
Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France. | Health Technology |
- Stock Market
- Insiders
- Alexandre Heraud
